Evidence that ceramide mediates the ability of tumor necrosis factor to modulate primitive human hematopoietic cell fates
Authors:
Open Access
- 15 December 2000
- journal article
- Published by American Society of Hematology in Blood
- Vol. 96 (13) , 4118-4123
Abstract
In this study, it is shown that short-term exposure of normal human marrow CD34+CD38− cells to low concentrations of tumor necrosis factor (TNF) in the presence of 100 ng/mL Flt3 ligand and Steel factor and 20 ng/mL interleukin-3 (IL-3), IL-6, and granulocyte colony-stimulating factor, in either bulk or single-cell serum-free cultures, markedly reduces their ability subsequently to generate colony-forming cells (CFCs) in 6-week stromal cell–containing long-term cultures without affecting their viability, mitogenic response, or short-term ability to produce CFCs. A similar differential effect on the functional attributes of CD34+CD38− cells was seen when C2- or C6-ceramide, but not dihydro-C2-ceramide (an inactive analog of ceramide), was substituted for TNF. The addition of D-erythro-MAPP (a specific inhibitor of intracellular ceramide degradation) enhanced the ability of TNF to selectively eliminate long-term culture–initiating cell (LTC-IC) activity. These findings indicate that TNF can directly modulate the ability of CD34+CD38− cells to maintain their LTC-IC function at doses below those required to initiate apoptosis, cell cycle arrest, or both, and they suggest that this may be mediated by the TNF-induced generation of intracellular ceramide. Identification of a signaling intermediate that can influence primitive hematopoietic cell fate decisions offers a new approach to the investigation of signaling mechanisms in normal stem cell populations and to how these may be altered in leukemic cells.Keywords
This publication has 43 references indexed in Scilit:
- Ontogeny‐associated changes in the cytokine responses of primitive human haemopoietic cellsBritish Journal of Haematology, 1998
- Efficient Retroviral-Mediated Gene Transfer to Human Cord Blood Stem Cells With In Vivo Repopulating PotentialBlood, 1998
- Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lympho-myeloid repopulating activity in nonobese diabetic– scid/scid miceProceedings of the National Academy of Sciences, 1997
- Quantitative Analysis Reveals Expansion of Human Hematopoietic Repopulating Cells After Short-term Ex Vivo CultureJournal of Experimental Medicine, 1997
- Purification of primitive human hematopoietic cells capable of repopulating immune-deficient miceProceedings of the National Academy of Sciences, 1997
- Cycle initiation and colony formation in culture by murine marrow cells with long-term reconstituting potential in vivoBlood, 1996
- Differential cytokine effects on primitive (CD34+CD38-) human hematopoietic cells: novel responses to Flt3-ligand and thrombopoietin.Journal of Experimental Medicine, 1996
- Differentiation and proliferation of hematopoietic stem cellsBlood, 1993
- Functional characterization of individual human hematopoietic stem cells cultured at limiting dilution on supportive marrow stromal layers.Proceedings of the National Academy of Sciences, 1990
- Clonal Hematopoiesis Demonstrated by X-Linked DNA Polymorphisms after Allogeneic Bone Marrow TransplantationNew England Journal of Medicine, 1989